80432-056-11 : NDC 2026 Code

80432-056-11 : Griseofulvin Oral Suspension ( Griseofulvin Oral Suspension )

Additionally :

You can get information about “80432-056-11” NDC code in 80432-056-11 in HTML format

HTML | 80432-056-11 in TXT (Plain Text) format

TXT | 80432-056-11 in PDF (Portable Document Format)

PDF | 80432-056-11 in XML format

XML formats.

NDC Code : 80432-056-11 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "80432-056-11",
    "PackageDescription": "118 mL in 1 BOTTLE (80432-056-11) ",
    "NDC11Code": "80432-0056-11",
    "ProductNDC": "80432-056",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Griseofulvin Oral Suspension",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Griseofulvin Oral Suspension",
    "DosageFormName": "SUSPENSION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20220809",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA065438",
    "LabelerName": "TriRx Huntsville Pharmaceutical Services LLC",
    "SubstanceName": "GRISEOFULVIN",
    "StrengthNumber": "125",
    "StrengthUnit": "mg/5mL",
    "Pharm_Classes": "Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2023-01-18",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20241231",
    "StartMarketingDatePackage": "20220809",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}